Lactulose exerts a beneficial effect on hepatic encephalopathy by decreasing toxic shortchain (iC4-nC6) fatty acid (isobutyrate, butyrate, isovalerate, valerate, isocaproate and caproate) production. However, the precise mechanism by which lactulose exerts this effect remains uncertain. This study investigated the effect of lactulose on faecal flora, particularly CZostridium difBciZe, which produces mostly iC4-nC6 fatty acids. An in-vitro faecal incubation system was used to estimate how lactulose influences production of short-chain (C2-nC6) fatty acids and lactate. Faecal specimens were collected from patients with liver cirrhosis, who carried C. difJiciZe in the colon. Supplementation of lactulose along with blood in faecal specimens decreased iC4-nC6 fatty acids production and increased acetate and lactate production, resulting in increased faecal acidity. These changes were statistically significant when compared with supplementation by blood alone. Quantitative faecal culture demonstrated that lactulose supplementation suppressed the growth of C. difJiciZe and Bacteroides spp. (B. fragilis group), iC4-nC6 fatty acids-producing organisms. These results suggest that decreased faecal levels of iC4-nC6 fatty acids after lactulose supplementation may be related to suppression of iC4-nC6 fatty acids-producing faecal organisms, especially C. difJicile.
Introduction
Cerebrotoxic substances derived from the gut such as ammonia, short-chain fatty acids (SCFAs), mercaptans and y-aminobutyric acids are thought to be responsible for hepatic encephalopathy (HE). While ammonia is most widely studied among these toxic substances, hyperammonaemia is not always associated with HE. Increased blood levels of isobutyrate (iC4), butyrate (nC4), isovalerate (iC5), valerate (nC5), isocaproate (iC6) and caproate (nC6) in patients with HE [l] and induction of HE by these SCFAs in animals [2] have been reported.
Lactulose is a disaccharide (/ 3 1-4 galacto-fructose) which has been used extensively since 1966 in the treatment of HE [3] . Taken orally, lactulose passes unchanged into the colon where it is hydrolysed by bacterial action to organic acids, principally acetate and lactate. Although the precise mode of action of lactulose remains unclear, proposed mechanisms are: (i) lowering colonic pH, thereby decreasing the production of ammonia by bacteria [4] and the absorption of non-ionised ammonia [5] ; (ii) serving as substrate to increase the incorporation of ammonia into bacterial protein [6] ; and (iii) decreasing the intestinal transit time available for production and absorption of ammonia because of its cathartic effect [7] . Mortensen et al. [8] showed that lactulose decreased the degradation of amino acids, albumin and blood to iC4-nC6 fatty acids by its acidifying effect.
The majority of SCFAs are produced by anaerobic bacteria that ferment dietary carbohydrates to SCFAs in the colon [9] . These bacteria include Clostridium spp., Bacteroides spp. (B. fragilis group), Fusobacterium spp. and Megasphaera spp. Among them, the Bacteroides spp. are one of the major components of intestinal flora, contributing to ammonia production but producing only a small amount of iC5. In contrast, C. perfringens produces a large amount of nC4 and C. dfjcile produces large amounts of iC4-nC6 fatty acids [lo, 111.
A previous study showed an overgrowth of C. d@cile and C. perfringens in the faecal flora of patients with HE, which was induced by administration of antimicrobial agents [12] . The rate of carriage of C. dficile was c. 20% in patients with liver cirrhosis (unpublished observations) and 7% in healthy elderly adults [ 131. Although these observations indicate that Clostridium spp. are of clinical importance in the development of HE, the effect of lactulose on C. perfringens has been examined in only a few studies [14, 151 and no report has focused on C. dzjicile.
The aim of this study was to evaluate the effect of lactulose on the faecal levels of SCFAs and lactate as well as on the growth of intestinal flora, especially C. difJiZe, with an in-vitro faecal incubation system, where faecal specimens containing C. d@cile were emp 1 oyed.
Materials and methods

Patients
Six inpatients with liver cirrhosis, who carried C. dzjicile, provided stool specimens. No antimicrobial agents had been prescribed during the 4 weeks prior to the study. Clinical characteristics and laboratory data on admission are shown in Table 1 . Two patients had mild diarrhoea while others had normal faeces.
Preparation of samples
The in-vitro faecal incubation system was similar to that of Mortensen et aZ. [16] . Freshly passed faeces were homogenised with five volumes of 100 mM NaCl and 50mM KC1. Ten ml of faecal homogenates were mixed with one of the following; blood (0.5 mll10 ml faecal homogenate), lactulose (25 mmol/L) and blood (0.5 mV10 ml faecal homogenate) or no addition. Each faecal sample was then incubated anaerobically at 37°C for 24 h in an atmosphere of N2 80%, H2 10% and c02 10%.
Bacteriological examination
One ml of the incubated faecal sample was homogenised with 9 ml of anaerobic diluent, and serial 10-fold dilutions were made to give a final dilution of lo7. Each odd number of logarithmic dilution was inoculated quantitatively onto the media shown in Table 2 . Aerobic and anaerobic cultures were incubated at 37°C for 72 h. The number of organisms was expressed as loglo cfdml of incubated faecal sample. Isolates were identified to genus level according to standard methods [lo, 11, 171.
Determination of SCFAs and lactate in incubated faecal samples
One ml of the incubated faecal sample was mixed with 0.1 ml of H2SO4 50% and 1 ml of diethyl ether, and centrifuged briefly to make an ether extract for the determination of SCFAs -acetate (C2), propionate (C3), iC4, nC4, iC5, nC5, iC6 and nC6 [lo] . For the determination of lactate, a mixture of 1 ml of the incubated faecal sample, 0.1 ml of H2S04 50% and 1 ml of (CH30H)2BF3 was heated at 100°C for 5 min and centrifuged briefly with 1 ml of chloroform to make a chloroform extract. These extracts were subjected to gas-liquid chromatography (Shimadzu GC-l4A, Shimadzu Corp., Kyoto, Japan) with a 1.6 m X 3.2-mm column packed with Reoplex 400 10% on Chromosorb W(AW-PMCS) (80-100 mesh).
Gas flows were 50 ml/min for N2, 50 ml/min for H2 and 1000 ml/min for air. Temperatures were kept at 150°C for the column and 220°C for the injector and the flame-ionisation detector.
Production of SCFAs and lactate by isolates from faeces
A standard loopful of isolate was inoculated into Gifu Anaerobic Medium (GAM) broth [ 181 (Nissui Pharmaceutical Co., Ltd) and incubated anaerobically at 37°C for 3-4 days. SCFAs and lactate production were determined as described above.
p H ana lys is
The pH of incubated faecal samples was measured with pH test paper (Advantec@, Toyo Roshi Co. Ltd, Tokyo, Japan).
Statistical methods
All comparisons were performed by paired t test with Statview software (Abacus Concepts Inc., Berkeley, CA, USA).
Results
SCFAs and lactate levels in incubated faecal s a mp 1 es
Following incubation, the faecal samples of all six individuals showed production of C2 -nC6 fatty acids. The addition of blood increased acetate, iC4-nC6 and lactate production while addition of lactulose extinguished the effect of blood on iC4-nC6 fatty acids production and increased faecal levels of acetate and lactate (Table 3) . A marked decrease in faecal pH was observed following the addition of lactulose.
Changes in faecal flora
The growth of C. dfficile, Bacteroides spp., BIJidobacterium spp. and Enterobacteriaceae was significantly suppressed by the addition of lactulose, while growth of C. perfringens was not suppressed (Table 4) . Lactobacillus spp. Enterobacteriaceae Total aerobes 9.3 SD 0.5 (6/6) 9.4 SD 0.4 (616) 8.8 SD 1.2 (6/6) 5.5 SD 1.8 (6/6) 6.1 SD 1.3 (6/6) 3.2 SD 0.8$ (516) 5.2 SD 1.8 (5/6) 5.2 SD 2.0 (5/6) 5.0 SD 1.9 (516) 8.6 SD 0.8 (6/6) 8.8 SD 0.5 (616) 3.7 SD 2.01 (416) 2.5 SD 1.2 (1/6) 2.5 SD 1.2 (116) ND* ND* ND* ND* 7.7 SD 2.9 (5/6) 7.7 SD 2.9 (5/6) ND+ 8.6 SD 0.4 (6/6) 8.9 SD 0.5 (616) 8.5 SD 0.5 (6/6) 7.7 SD 1.0 (6/6) 7.8 SD 1.1 (6/6) 8.3 SD 0.7 (6/6) 6.7 SD 2.1 (6/6) 7.0 SD 1.9 (616) 2.3 SD 0.7+ (1/6)
~ ~~~
Figures in parentheses are frequency of occurrence (number of subjects yielding the organisms/ number of subjects examined). *ND (not detectable) is calculated as 2.0.
tp < 0.01 versus blood. lp < 0.001 versus blood.
Lactobacillus spp. became the major component after lactulose was added to faecal samples.
SCFAs and lactate production by faecal isolates
Bacteroides isolates produced iC5, Fusobacterium and C. pe$+zgens isolates produced nC4, while C. difJicile isolates produced iC4-nC6 fatty acids.
Discussion
Although the precise mode of action of lactulose has not been clarified, one of the speculated mechanisms is the acidification of the colon contents by fermented products of lactulose. Mortensen et al. [16] showed that iC4-nC6 fatty acid production by faecal flora was increased by the addition of blood, albumin and amino acids but decreased by adding lactulose in vitro. They initially suggested that this effect was the result of substrate competition, i.e., colonic bacteria preferred lactulose to blood when both were present. Later it was reported that the acidifying effect of lactulose was more important in decreasing iC4-nC6 fatty acids production [8] .
The present study confirmed that the addition of lactulose decreased faecal levels of iC4-nC6 fatty acids, increased acetate production and reduced faecal pH. It further demonstrated that lactulose caused an increase in lactate production in the faecal incubation system, which contributed to an increase in faecal acidity. Of particular importance was the finding that the growth of both C. dfjcile (mostly iC4-nC6 fatty acid-producing) and Bacteroides spp. (iC5-producing) was suppressed by lactulose.
The growth of C. dffcile is particularly susceptible to changes in colonic acidity [19] . Rolfe et al. [20] showed that, in vitro, Lactobacillus spp. and group D enterococci produced large amounts of lactate that inhibited the growth of C. diffile. They also suggested that SCFAs played an important role in the induction of colonisation resistance against C. dficile in a conventional hamster model [21] . The invitro study by May et al. [22] suggested that acidification with SCFAs produced by fermentation of dietary fibre suppressed C. dfjcile.
The study data can be interpreted as follows: acidification with acetate and lactate produced by fermentation of lactulose suppressed faecal anaerobes, especially C. difJicile, resulting in a decrease of iC4-nC6 fatty acids production. Furthermore, a poorly absorbed disaccharide, lactitol, which was shown to improve HE, induces colonic acidification to a similar degree to lactulose [28] . Oligosaccharides taken orally significantly increased the number of BiJidobacterium spp. in human faecal flora [29] . Dietary fibre, which escapes from host digestion and is fermented to acetate, propionate and butyrate in the colon [9] , was shown to increase the number of acid-producing bacteria but decrease the number of C. dificile and resultant toxin [22] . A vegetable protein diet supplemented with dietary fibre was also effective in HE [30] . In addition to lactulose, these substances may also exert a beneficial effect on HE by suppressing the growth of the iC4-nC6 fatty acids-producing organisms, C. dzfJicile and Bacteroides spp., through colonic acidification. Further invivo studies are needed to establish the mechanisms of action of these substances.
